Abiopharma

🔍 Steele Barron Elliot (Executive)

Company: Frontier Group Holdings, Inc. (ULCC)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 22,284 shares of Deferred Stock Units (Derivative)
  Date: 2026-06-15 | Code: A | equity_swap_involved: false | shares_owned_after: 22,284.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each Deferred Stock Unit represents a contingent right to receive one share of Issuer Common Stock. The Deferred Stock Units have no expiration date.
• F2: The Deferred Stock Units will vest in full on the earlier of May 14, 2027 or immediately prior to the next annual meeting of stockholders after the grant date, subject to continued service of the Reporting Person through the vesting date and will be settled in shares of the Issuer's Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Program (the "Plan"), or (ii) as otherwise provided by the Plan.